International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.12780028
Original Research Article
Does the size of antral follicle matter? Relation of FORT to follicular diameter in stimulation protocol
Published
Feb. 24, 2025
Abstract

Background: This study aimed to investigate whether the diameter of antral follicles, specifically comparing those with diameters of 6 mm or less (AFC≤6) versus those greater than 6 mm (AFC > 6), can predict ovarian responsiveness, as assessed by the Follicular Output Rate (FORT) in women undergoing IVF treatment.138 women with regular menstrual cycles and no ovarian abnormalities, undergoing controlled ovarian hyperstimulation (COH) were included in this study. Number and size of antral follicles were noted on day 2 of cycle. Number of pre ovulatory follicles were noted and FORT was calculated on day of trigger with HCG. The correlation among FORT with age, AFC ≤ 6, AFC > 6, number of oocytes, body mass index (BMI), and antiMullerian hormone (AMH) were also assessed. Result: The mean age of the women was 31.36  (± 3.28) years, the mean FORT was 53.453. We found positive correlation between the FORT and antral follicles with diameter ≤6mm (r= 0.467, P  6mm in diameter (r = − 0.436, P<0.001). Conclusion: Ovarian responsiveness, as indicated by the Follicular Output Rate (FORT), was positively correlated with the presence of smaller antral follicles (AFC ≤6mm).

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
1841 Views
268 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved